Work

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Year: 2014

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt573

Authors: H.A. Yu, M.E. Arcila, M.D. Hellmann, M.G. Kris, M. Ladanyi, G.J. Riely

Institutions: Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G2684890037, Cancer Center Support Grant

OpenAlex ID: W2133283856

FWCI: 18.89

Cites: 27

Cited by: 205

Related to: 10